Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06554652

Selective Neck Dissection Versus Modified Neck Dissection in PTC

Tracer Navigated Selective Neck Dissection Versus Modified Neck Dissection in Papillary Thyroid Cancer With Limited Lymph Node Metastasis in the Lateral Neck: A Randomized, Noninferiority Phase III Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the primary endpoint. The aim of the study is to evaluate the safety of selective neck dissection in papillary carcinoma with limited number of lymph node metastases in the lateral neck, and the quality of life compared with modified neck dissection.

Conditions

Interventions

TypeNameDescription
PROCEDURELymph node tracer navigated selective neck dissectionSelective lateral lymph node dissection (after injection of tracer, lymph nodes in compartment III-IV are dissected; if there is dyed lymph node in compartment IIA, then IIA is dissected).
PROCEDUREModified neck dissectionLymph nodes in compartment IIA, IIB, III, IV, VB are dissected.

Timeline

Start date
2024-11-19
Primary completion
2029-06-30
Completion
2029-06-30
First posted
2024-08-15
Last updated
2026-02-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06554652. Inclusion in this directory is not an endorsement.